(Speaker Term: 7/1/13 - 6/30/15)
Department of Immunology & Infectious Diseases
Harvard School of Public Health
665 Huntington Avenue
Boston, MA 02115
Fax: 617-432-4677 (c/o Colleen Saville)
LECTURE TOPICS AND DESCRIPTIONS
Whither Malaria? From Control to Eradication
The malaria public health paradigm is shifting from control to elimination and eradication. What is the progress at the front line, what are we learning, and what are the critical knowledge gaps and research questions?
How Does Basic Science Translate into Usable Interventions in Neglected Diseases?
The new focus on neglected infectious diseases challenges every aspect of science and public health, from basic discoveries to interventions (drugs, vaccines, and vector-based interventions), as well as strategies to finance and delivery. Progress and lessons will be drawn from the fields of malaria, guinea worm, dengue, Chagas, and others.
Impact of Philanthropic and Not-for-Profit Organizations on Global Health Policy: Malaria as a Case Study
The global health agenda has become increasingly complex, with new actors, organizations, and ways of engaging and showing results. Malaria illustrates the story – how products are developed, policies are set, projects become national programs, global targets are drawn, and impact is measured.
BIOGRAPHICAL SKETCH – Regina Rabinovich
Dr. Regina Rabinovich is a global health executive with over 25 years of experience in the research, public health, and philanthropic sectors, with focus on strategy, analytics, global health product development, and the introduction and scale-up of tools and strategies resulting in impact on endemic populations. She is currently serving as the ExxonMobil Malaria Scholar in Residence at Harvard University. Prior to joining Harvard, she served as Director of the Infectious Diseases Unit at the Bill & Melinda Gates Foundation (from 2003-2012), overseeing the development and implementation of strategies for the prevention, treatment, and control of diseases of particular relevance to global health, including malaria, pneumonia, diarrhea, and neglected infectious diseases.
Dr. Rabinovich has also served in various positions at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines. She participated in the Children's Vaccine Initiative, a global effort to prevent infectious diseases in children in the developing world, and served as liaison to the National Vaccine Program Office, focusing on vaccine safety and vaccine research. As chief of the Clinical and Regulatory Affairs Branch of the Division of Microbiology and Infectious Diseases, she managed the evaluation of candidate vaccines through a network of U.S. clinical research units.
In 1999, Rabinovich became director of the PATH Malaria Vaccine Initiative, a project funded by the Bill & Melinda Gates Foundation to advance efforts to develop promising malaria vaccine candidates. She joined the foundation in 2003. She serves on the boards of several organizations focused on global health and infectious diseases, including the NIAID Council and the NIH Council on Councils, PATH Vaccine Solutions, and AERAS.
Dr. Rabinovich holds a medical degree from Southern Illinois University and a Master of Public Health degree from the University of North Carolina. Her undergraduate degree is from the University of Iowa.
ASM MEMBERSHIP AFFILIATION – Regina Rabinovich
Primary Division: Y (Public Health)
Secondary Division: L (Healthcare Epidemiology)